Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 9 EQ Equillium GAAP EPS of -$0.08, revenue of $10.7M
May 9 EQ Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
May 9 EQ Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
May 9 CYTK Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
May 9 CYTK Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
May 9 CYTK Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript
May 8 CYTK Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
May 8 CYTK Cytokinetics GAAP EPS of -$1.33 misses by $0.18, revenue of $0.84M misses by $0.07M
May 8 CYTK Cytokinetics Reports First Quarter 2024 Financial Results
May 8 FGEN FibroGen First Quarter 2024 Earnings: Beats Expectations
May 8 CYTK Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
May 8 CYTK Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 8 CLDX Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 CYTK Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
May 7 CYTK Cytokinetics Q1 2024 Earnings Preview
May 7 CPIX Cumberland Pharmaceuticals Non-GAAP EPS of -$0.05, revenue of $8.5M
May 7 CPIX Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
May 7 CYTK Cytokinetics to Hold Annual Meeting of Stockholders
May 7 FGEN FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags